MAP is a metalloenzyme encoded by the map gene in E. coli. It catalyzes the removal of N-terminal methionine residues from nascent proteins, a vital step in protein maturation.
MAP activity is critical for processing recombinant proteins like interleukin-2 and ricin A .
Substrate specificity depends on residues adjacent to methionine, influencing cleavage efficiency .
The Map (mitochondria-associated protein) effector is produced by enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC). It disrupts host cell functions during infection.
Map expression peaks early in infection (≤1 day) but is suppressed by day 4, coinciding with reduced EPEC colonization .
Competitive colonization assays confirm Map’s role in sustaining infection .
Aspect | Methionine Aminopeptidase (MAP) | Map Effector Protein |
---|---|---|
Gene/Protein | map gene; metabolic enzyme | map gene; virulence factor |
Biological Role | Protein maturation | Host cell disruption, pathogenicity |
Expression Context | Constitutive in all E. coli strains | Induced in EPEC/EHEC during infection |
Therapeutic Relevance | Potential antibiotic target (metabolic inhibition) | Vaccine/drug target (anti-virulence) |
The thermal inactivation of E.coli follows specific temperature-dependent kinetics that researchers must understand when designing experiments. E.coli begins to be inactivated at 140°F (60°C), with destruction rates increasing significantly at higher temperatures . For research protocols, consider:
At 140°F: Initial inactivation occurs, requiring extended exposure time
At 160°F: Rapid inactivation occurs within minutes
Higher temperatures accelerate destruction rates substantially
It's methodologically important to note that even after thermal destruction of E.coli cells, toxins may remain bioactive in experimental samples, as E.coli is a toxin producer . This presents significant considerations for designing thermal inactivation studies and interpreting results.
When implementing thermal inactivation protocols, researchers should establish clear time-temperature parameters and validate inactivation through culture-based confirmation rather than assuming complete destruction based solely on exposure parameters.
Methodologically sound source attribution requires systematic evaluation of potential contamination vectors. When investigating outbreaks, researchers must consider:
Food matrix analysis: Different food components carry varying risks (raw vegetables versus cooked meat)
Cross-contamination pathways: Transfer mechanisms between food items
Processing interventions: Efficacy of control measures at different production stages
Current research suggests that many E.coli outbreaks involve contaminated vegetables rather than properly cooked meat products, as demonstrated in multiple outbreaks where secondary ingredients (onions, lettuce, pickles) were implicated . Methodologically, researchers should employ:
Parallel testing of all potential sources
Molecular typing to match clinical and food isolates
Detailed food preparation workflow analysis
Statistical analysis of case-control consumption patterns
This multi-faceted approach allows for discrimination between primary contamination sources and secondary vectors in complex outbreak scenarios.
Designing robust chemical interaction studies requires a structured methodological framework. For comprehensive analysis of chemical-chemical interactions affecting E.coli, implement:
Systematic checkerboard assays with concentration-dependent analysis
Standardized growth conditions using defined media (e.g., M9 minimal medium)
Clear classification criteria for synergistic, antagonistic, or indifferent interactions
Comprehensive compound selection targeting diverse cellular pathways
A methodologically sound approach involves testing chemical probes systematically across multiple targets. Recent research demonstrated this by evaluating 45 compounds (990 unique combinations) that probe bacterial functions in nutrient synthesis and housekeeping functions .
Interaction Type | Number Observed | Percentage of Total |
---|---|---|
Synergistic | 83 | 44.6% |
Antagonistic | 62 | 33.3% |
Indifferent | 41 | 22.1% |
Total | 186 | 100% |
When designing such studies, control for:
Solvent effects through appropriate vehicle controls
Growth phase variations by standardizing inoculation procedures
Medium-specific effects by including nutrient supplementation controls
Technical variation through sufficient biological and technical replicates
This systematic methodology enables identification of previously uncharacterized interactions between compounds affecting different cellular processes.
Investigating pathway-specific inhibition under nutrient limitation requires integrated methodological approaches that combine:
Selective chemical probes targeting specific biosynthetic steps
Genetic validation using knockout or complementation strategies
Metabolic profiling to monitor pathway intermediates
Growth phenotyping under controlled nutrient availability
Research demonstrates the effectiveness of this approach in elucidating cross-pathway interactions. For example, L-norleucine inhibits methionine adenosyltransferase (MetK), preventing S-adenosylmethionine (SAM) production, which is required for the first biotin biosynthetic step . When combined with MAC13772 (an inhibitor of a late biotin biosynthesis step), researchers observed synergistic growth inhibition that revealed pathway interconnections.
The methodological workflow should include:
Preliminary characterization of individual inhibitor effects
Dose-response analysis under varying nutrient conditions
Supplementation studies with pathway end-products
Temporal analysis of inhibition effects
This integrated approach enables researchers to map complex metabolic networks and identify vulnerabilities specific to nutrient-limited conditions relevant to infection environments.
Robust statistical analysis of outbreak geographic distribution requires:
Spatial cluster detection methods (e.g., spatial scan statistics)
Demographic normalization to account for population density variations
Time-series analysis to track directional spread
Supply chain network analysis for commercial product outbreaks
The recent multi-state E.coli outbreak linked to fast-food products demonstrates the importance of geographic analysis, as cases clustered predominantly in western states including Colorado, Wyoming, Montana, Nebraska, and others .
When designing geospatial analyses, researchers should:
Establish appropriate denominators for rate calculations
Account for reporting biases between jurisdictions
Consider environmental factors influencing pathogen survival
Integrate distribution network data for commercial products
This methodological framework enables differentiation between random case distribution and significant geographical clustering, providing critical insights for outbreak source identification.
Discriminating between environmental persistence and ongoing transmission requires carefully designed experimental approaches:
Whole genome sequencing with high-resolution phylogenetic analysis
Temporal sampling to establish genetic drift rates
Environmental sampling protocols with sensitivity controls
Experimental models of environmental persistence under relevant conditions
Methodologically, researchers must implement:
Standardized sampling procedures across timepoints
Molecular clock analysis to estimate divergence timing
Matched clinical-environmental sampling
Controlled persistence studies mimicking outbreak conditions
This approach enables determination of whether new cases result from continued exposure to a persistent environmental reservoir or represent ongoing person-to-person or food-to-person transmission events, which has significant implications for intervention strategies.
Investigation of biotin biosynthesis inhibition requires specific methodological considerations:
Selective targeting of pathway-specific enzymes
Analysis of pathway intermediates using LC-MS/MS
Genetic validation using biotin auxotrophs
Growth phenotyping under biotin-limited conditions
Research has demonstrated the effectiveness of this approach by targeting different steps in the biotin biosynthetic pathway. The biotin pathway in E.coli involves SAM-dependent methylation in the initial step, creating interaction opportunities with methionine metabolism . Studies using inhibitors like MAC13772 targeting the antepenultimate step of biotin biosynthesis provide insights into pathway vulnerability.
When designing biotin pathway studies, researchers should:
Include biotin supplementation controls
Consider the temporal sequence of enzymatic reactions
Account for potential pathway compensation mechanisms
Integrate transcriptomic analysis to detect regulatory responses
This comprehensive approach enables detailed characterization of this essential pathway and identification of potential synergistic inhibition strategies.
Methodological approaches for studying fatty acid biosynthesis interconnections require:
Selective inhibition of condensing enzymes (e.g., FabB)
Membrane composition analysis using lipidomics
Metabolic flux analysis with labeled precursors
Integration with other biosynthetic pathway analyses
Research has established that β-ketoacyl-ACP synthase I (FabB), essential for fatty acid biosynthesis, also participates in elongating biotin's saturated chain moiety . This dual role highlights the interconnection between fatty acid metabolism and cofactor biosynthesis.
The experimental workflow should include:
Selective inhibition studies using pathway-specific compounds
Complementation assays with pathway intermediates
Membrane integrity assessment following inhibition
Transcriptional analysis of compensatory responses
This integrated methodological approach reveals the complex relationship between fatty acid biosynthesis and other essential pathways, providing insights into potential multi-target inhibition strategies.
Robust investigation of synergistic antibiotic interactions requires structured methodological approaches:
Standardized checkerboard assays with concentration matrices
Time-kill kinetics to distinguish bacteriostatic versus bactericidal effects
Mechanism of action studies to determine interaction basis
In vivo validation using appropriate infection models
Research has identified unexpected synergistic interactions, such as the potentiation of the typically Gram-positive antibiotic novobiocin against E.coli through combination with cell wall-active antibiotics like vancomycin and fosmidomycin . These unexpected synergies demonstrate the importance of systematic screening approaches.
When designing antibiotic interaction studies, researchers should implement:
Methodological Consideration | Implementation Approach |
---|---|
Concentration range selection | Include sub-inhibitory to fully inhibitory |
Interaction quantification | Calculate fractional inhibitory concentration indices (FICI) |
Temporal analysis | Assess interactions at multiple timepoints |
Mechanism validation | Perform genetic or biochemical target confirmation |
This structured approach enables identification of clinically relevant synergistic combinations and elucidation of their mechanistic basis.
Methodological approaches for studying housekeeping function inhibitors require:
Clear categorization of inhibitor classes based on cellular targets
Multi-parameter phenotypic analysis beyond growth inhibition
Target engagement validation through biochemical or genetic approaches
Consideration of conditional essentiality under different growth conditions
Research utilizing 27 housekeeping function probes demonstrated the importance of systematic interaction analysis . When studying compounds that target cell wall synthesis, protein synthesis, or DNA replication, researchers should:
Establish clear phenotypic readouts for each functional class
Include corresponding positive controls for each mechanism
Consider growth condition-dependent effects on target essentiality
Implement resistance development analysis
This comprehensive approach enables characterization of compounds affecting core cellular functions and identification of potential combination strategies to enhance antimicrobial efficacy or prevent resistance development.
Methionine Aminopeptidase is a metalloenzyme, meaning it requires metal ions for its catalytic activity. The active site of MAP contains two adjacent divalent metal ions, typically cobalt (Co²⁺) or nickel (Ni²⁺), connected by a water molecule or hydroxide ion . These metal ions are essential for the enzyme’s function, as they facilitate the hydrolysis of the peptide bond at the N-terminal methionine.
Recombinant expression of Methionine Aminopeptidase in Escherichia coli (E. coli) involves the insertion of the gene encoding MAP into an E. coli expression system. This allows for the production of large quantities of the enzyme for research and industrial applications. The recombinant MAP is typically fused to a His-tag at the N-terminus, which aids in its purification using affinity chromatography techniques .
The recombinant E. coli Methionine Aminopeptidase has been characterized to have a molecular mass of approximately 31 kDa . It is a single, non-glycosylated polypeptide chain containing 284 amino acids . The enzyme exhibits high specificity for substrates with a methionine residue at the N-terminus and non-bulky, uncharged amino acids at the penultimate position .
Methionine Aminopeptidase is widely used in various biochemical and biotechnological applications. Its ability to remove the N-terminal methionine from recombinant proteins makes it valuable in protein engineering and production. Additionally, MAP is a potential target for the development of antibacterial drugs, as the NME process is essential for bacterial survival .